Contract manufacturing experts, Mediliant today announced the addition of Philip Penn as their new VP of Sales and Marketing. The addition of Mr. Penn further strengthens the organization’s commercial team, laying a strong foundation for growth as they continue to serve the Medical Device Industry.
With nearly two decades of experience in sales and even more years of expertise in the Medical Device Industry, Philip Penn will play a key role in building Mediliant’s marketing structure and expanding the company’s commercial capabilities to further serve their customers. Before joining Mediliant, Mr. Penn held roles as Director of Sales in Orthopedics for LISI Medical and Regional Sales Director for RD&D Sales Engineering.
“Philip Penn’s new role as VP of Sales and Marketing comes at a crucial time as the company goes through a major rebrand. Philip will be responsible for maintaining and developing customer relationships and developing marketing and commercial strategies that will ensure customer success and the growth of Mediliant as they transition into the new Mediliant Group. The new Mediliant Group, made up of Mediliant, MDI, and CTE, will have a major impact on the Medical Device Industry as the three organizations join forces to provide a customized, MedTech experience and strengthen their capabilities in extremities, spine, and trauma.”- Denis Leissing, CEO of Mediliant.
With the expansion of the Mediliant Group, the addition of Philip Penn to the commercial team is going to be a key factor in Mediliant Group’s growth and vision of becoming a global leader in the Medical Device Industry and strengthen their capabilities in extremities, spine, and trauma.